Randomized phase II study comparing docetaxel plus cisplatin , docetaxel plus carboplatin , and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma : a Japanese Gynecologic Oncology Group study ( JGOG 2041 )
暂无分享,去创建一个
M. Hatae | N. Yaegashi | I. Konishi | T. Jobo | D. Aoki | H. Nomura | N. Katsumata | F. Takahashi | Y. Watanabe | M. Hiura